Company profile for Heidelberg Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Heidelberg Pharma is a biopharmaceutical company pioneering antibody-drug conjugate (ADC) therapies for targeted cancer treatment. By combining antibodies with powerful cytotoxic agents, their ADCs deliver toxins directly into cancer cells, where they release their payload to destroy the diseased cells. This innovative approach offers a highly specific and effective way to treat cancer while minimizing damage to healthy tissue...
Heidelberg Pharma is a biopharmaceutical company pioneering antibody-drug conjugate (ADC) therapies for targeted cancer treatment. By combining antibodies with powerful cytotoxic agents, their ADCs deliver toxins directly into cancer cells, where they release their payload to destroy the diseased cells. This innovative approach offers a highly specific and effective way to treat cancer while minimizing damage to healthy tissue.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Schlo
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Arvo

Arvo

Not Confirmed

envelop Contact Supplier

Arvo

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-11-06/heidelberg-pharma-s-lead-atac-candidate-hdp-101-shows-progress-in-phase-iiia-trial-in-multiple-myeloma

PHARMIWEB
06 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-05/heidelberg-pharma-to-present-new-clinical-data-of-lead-adc-candidate-hdp-101-at-the-world-adc-congress-2025-and-to-host-webinar

PHARMIWEB
05 Nov 2025

https://www.indianpharmapost.com/drug-approval/fda-grants-fast-track-status-to-heidelberg-pharmas-amanitin-based-adc-candidate-for-multiple-myeloma-18090

INDPHARMAPOST
29 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-23/heidelberg-pharma-s-lead-adc-candidate-hdp-101-granted-fast-track-designation-by-us-fda-for-the-treatment-of-multiple-myeloma

PHARMIWEB
23 Oct 2025

https://www.biospace.com/business/heidelberg-pharma-misses-out-on-royalty-payment-plans-75-workforce-cut

BIOSPACE
26 Sep 2025

https://www.fiercebiotech.com/biotech/heidelberg-lay-75-staff-after-milestone-becomes-millstone

FIERCE BIOTECH
25 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty